Fig. 2.

Effect modification of baseline anaemia and iron status on Hb and iron status at end line among young children who received either a low-iron-, high-zinc-containing micronutrient powder (▪) or a placebo powder (◻). Only selected significant or marginally significant effect modifications are shown; a complete overview of effect modifications is included in Table 4. Iron status indicators adjusted for inflammation. Continuous outcomes log transformed for analysis. sTfR, soluble transferrin receptor. Values are means, with standard deviations represented by vertical bars.